Joonas Haapasalo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joonas Haapasalo has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
- Kristiina Nordfors
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada
12 shared publications - Alexandra Rasnitsyn
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada
11 shared publications - Ana Guerreiro Stucklin
Division of Oncology and Children’s Research Center, University Children’s Hospital of Zurich, Zurich, Switzerland
11 shared publications - Borja L. Holgado
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada
11 shared publications - Celio Pouponnot
Institut Curie, Orsay, France
11 shared publications - Cory M. Richman
The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Canada
11 shared publications
Latest Publications
- Open Access
- 11 June 2026
- Published by Elsevier in SSRN Electronic Journal
Structural Connectivity of the Anterior Thalamic Subregions:Advancing Personalized Approaches for Targeting Specific Networks in Drug-resistant Epilepsy
Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an established therapy for drug-resistant epilepsy (DRE), yet the optimal stimulation targets and underlying network mechanisms remain unclear. This study employed high angular resolution diffusion weighted imaging (HARDI) and multi-shell multi-tissue constrained spherical deconvolution (MSMT-CSD) tractography in 13 healthy volunteers to map the structural connectivity of five anterior thalamic subregions: 1) anteromedial nucleus (AM), 2) anteroventral nucleus (AV), 3) dorsal superficial nucleus (DSF), 4) AV–mammillothalamic tract junction (AVmtt), and 5) external medullary lamina (EML) at the superolateral aspect of AV. Probabilistic tractography was used as the primary analytical approach due to its increased sensitivity to complex fiber configurations compared to deterministic methods. The results indicated that AM, AV, and DSF subnuclei connect inferiorly via inferior thalamic peduncle to the amygdala and posteriorly via temporopulvinar tract to the dorsal hippocampus, with AM also projecting to the orbitofrontal cortex via anterior thalamic radiation. AVmtt indicated a strong connection to the orbitofrontal cortex and dorsal hippocampus, while EML exhibited extensive connectivity via anterior and posterior thalamic radiations to orbitofrontal-, medial prefrontal-, cingulate-, parietal-, and occipital cortices in addition to the connection to the cingulum bundle but lacked inferior connections including amygdala. These findings demonstrate that anterior thalamic subregions possess distinct yet consistent connectivity patterns, supporting connectivity-informed, network-specific targeting strategies to optimize therapeutic outcomes in drug-resistant epilepsy.
- 11 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessStructural Connectivity of the Anterior Thalamic Subregions:Advancing Personalized Approaches for Targeting Specific Networks in Drug-resistant Epilepsy
Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an established therapy for drug-resistant epilepsy (DRE), yet the optimal stimulation targets and underlying network mechanisms remain unclear. This study employed high angular resolution diffusion weighted imaging (HARDI) and multi-shell multi-tissue constrained spherical deconvolution (MSMT-CSD) tractography in 13 healthy volunteers to map the structural connectivity of five anterior thalamic subregions: 1) anteromedial nucleus (AM), 2) anteroventral nucleus (AV), 3) dorsal superficial nucleus (DSF), 4) AV–mammillothalamic tract junction (AVmtt), and 5) external medullary lamina (EML) at the superolateral aspect of AV. Probabilistic tractography was used as the primary analytical approach due to its increased sensitivity to complex fiber configurations compared to deterministic methods. The results indicated that AM, AV, and DSF subnuclei connect inferiorly via inferior thalamic peduncle to the amygdala and posteriorly via temporopulvinar tract to the dorsal hippocampus, with AM also projecting to the orbitofrontal cortex via anterior thalamic radiation. AVmtt indicated a strong connection to the orbitofrontal cortex and dorsal hippocampus, while EML exhibited extensive connectivity via anterior and posterior thalamic radiations to orbitofrontal-, medial prefrontal-, cingulate-, parietal-, and occipital cortices in addition to the connection to the cingulum bundle but lacked inferior connections including amygdala. These findings demonstrate that anterior thalamic subregions possess distinct yet consistent connectivity patterns, supporting connectivity-informed, network-specific targeting strategies to optimize therapeutic outcomes in drug-resistant epilepsy.
- Open Access
Hypoxia and Associated Acidosis Generate Cell-Type Specific Myeloid Responses in Glioblastoma
Hypoxia is a defining feature of glioblastoma (GBM), yet how it cooperates with hypoxia-associated acidosis to shape microglia and infiltrating monocyte-derived macrophages (MDM) remains poorly understood. We integrated cyclic immunohistochemistry, single-cell RNA sequencing, spatial transcriptomics, in vitro cell cultures, and DNA methylation profiling to outline hypoxia-driven responses in up to 136 GBMs. These hypoxic niches were selectively enriched for MDMs that activated carbonic anhydrase (CA) mediated pH buffering and other metabolic adaptation programs, enabling survival in acidic hypoxia, increasingly interacted with cancer cells, and show polarization toward immunosuppressive myeloid-derived suppressor cell (MDSC)-like states. In contrast, microglia were depleted in hypoxic areas, lacked compensatory CA isoenzymes, and developed TNF-linked stress responses and loss of homeostatic identity in acidic hypoxia. These findings identify metabolic adaptation to hypoxia-associated microenvironmental stress as a key determinant of GBM immune architecture, driving myeloid cell fates, spatial TME reorganization and the emergence of immunosuppressive tumor ecosystems.
Open AccessHypoxia and Associated Acidosis Generate Cell-Type Specific Myeloid Responses in Glioblastoma
Hypoxia is a defining feature of glioblastoma (GBM), yet how it cooperates with hypoxia-associated acidosis to shape microglia and infiltrating monocyte-derived macrophages (MDM) remains poorly understood. We integrated cyclic immunohistochemistry, single-cell RNA sequencing, spatial transcriptomics, in vitro cell cultures, and DNA methylation profiling to outline hypoxia-driven responses in up to 136 GBMs. These hypoxic niches were selectively enriched for MDMs that activated carbonic anhydrase (CA) mediated pH buffering and other metabolic adaptation programs, enabling survival in acidic hypoxia, increasingly interacted with cancer cells, and show polarization toward immunosuppressive myeloid-derived suppressor cell (MDSC)-like states. In contrast, microglia were depleted in hypoxic areas, lacked compensatory CA isoenzymes, and developed TNF-linked stress responses and loss of homeostatic identity in acidic hypoxia. These findings identify metabolic adaptation to hypoxia-associated microenvironmental stress as a key determinant of GBM immune architecture, driving myeloid cell fates, spatial TME reorganization and the emergence of immunosuppressive tumor ecosystems.
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
Supplementary Table 2 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
Supplementary Table 2 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
Supplementary Table 1 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
Supplementary Table 1 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- Open Access
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy
- 1 October 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy